Научно-практическая ревматология (Sep 2016)
TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS
- S. A. Lapshina,
- T. V. Dubinina,
- V. V. Badokin,
- A. G. Bochkova,
- O. V. Bugrova,
- I. Z. Gaidukova,
- A. A. Godzenko,
- A. A. Dubikov,
- O. N. Ivanova,
- T. V. Korotaeva,
- O. B. Nesmeyanova,
- I. P. Nikishina,
- E. N. Otteva,
- T. A. Raskina,
- A. P. Rebrov,
- O. A. Rumyantseva,
- A. V. Sitalo,
- A. V. Smirnov,
- Sh. F. Erdes
Affiliations
- S. A. Lapshina
- Kazan State Medical University, Ministry of Health of Russia; Kazan
- T. V. Dubinina
- V.A. Nasonova Research Institute of Rheumatology, Moscow
- V. V. Badokin
- Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow
- A. G. Bochkova
- Agat Medical Center, Egoryevsk, Moscow Region
- O. V. Bugrova
- Orenburg State Medical University, Ministry of Health of Russia, Orenburg
- I. Z. Gaidukova
- V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia, Saratov
- A. A. Godzenko
- Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow
- A. A. Dubikov
- Pacific State Medical University, Ministry of Health of Russia, Vladivostok
- O. N. Ivanova
- Voronezh Regional Clinical Hospital One, Voronezh
- T. V. Korotaeva
- V.A. Nasonova Research Institute of Rheumatology, Moscow
- O. B. Nesmeyanova
- Chelyabinsk Regional Clinical Hospital, Chelyabinsk
- I. P. Nikishina
- V.A. Nasonova Research Institute of Rheumatology, Moscow
- E. N. Otteva
- Institute for Advanced Training of Healthcare Specialists, Ministry of Health of the Khabarovsk Territory, Khabarovsk
- T. A. Raskina
- Kemerovo State Medical Academy, Ministry of Health of Russia, Kemerovo
- A. P. Rebrov
- V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia, Saratov
- O. A. Rumyantseva
- V.A. Nasonova Research Institute of Rheumatology, Moscow
- A. V. Sitalo
- Society of Mutual Assistance in Bechterew's Disease, Moscow
- A. V. Smirnov
- V.A. Nasonova Research Institute of Rheumatology, Moscow
- Sh. F. Erdes
- V.A. Nasonova Research Institute of Rheumatology, Moscow
- DOI
- https://doi.org/10.14412/1995-4484-2016-1S-75-79
- Journal volume & issue
-
Vol. 54,
no. 1S
pp. 75 – 79
Abstract
The paper provides guidelines for the use of tumor necrosis factor-α (TNF-α) inhibitors in the treatment of patients with axial spondyloarthritis (axSpA), including ankylosing spondylitis. It gives data on the efficacy of TNF-α inhibitors in patients with non-radiographic axSpA. By using international and Russian guidelines, the authors lay down indications for this therapy and criteria for evaluation of its efficiency and safety.
Keywords
- axial spondyloarthritis
- ankylosing spondylitis
- tumor necrosis factor-α (tnf-α) inhibitors
- efficacy
- safety
